Marksans Pharma announces USFDA approval for Famotidine Tablets

Marksans' OTC Famotidine Tablets USP are acid reducers

USFDA completes inspection of Lupin’s Vizag facility

The inspection concluded with no observations

Build a sustainable healthcare and lifesciences industry, say Experts

Time to combine innovation, access and technology to deliver positive patient outcomes

Bachem raises $116 million through capital increase

Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies

NATCO launches additional strengths for generic version of Revlimid in USA

Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.

Zydus receives final approval from the USFDA for Erythromycin Tablets

Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body

Clariant launches Plantasens Pro LM

Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified

SRL Diagnostics partners with PathPresenter to enable digital pathology consultations

This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images

Alembic receives USFDA tentative approval for Brexpiprazole Tablets

Alembic receives USFDA final approval for Prazosin Hydrochloride Capsules

Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure